Akèy › Skleroz Miltip › Distrik Columbia › Washington
Etid klinik pou Skleroz Miltip nan Washington, DC
13 etid pou Skleroz Miltip ap chèche patisipan nan sit nan ak bò kote Washington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques
Ap rekriteFaz 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Ap rekriteFaz 1
- MedStar Georgetown University Hospital, Washington D.C.
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi lwen
Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)
Ap rekriteFaz 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Ap rekriteEtid obsèvasyon
- TG Therapeutics Investigational Trial Site, Washington D.C.
Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
An Open-label Study of AZD0120 in Adults With Multiple Sclerosis
Ap rekriteFaz 1
- Research Site, Washington D.C.
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Ap rekriteFaz 3
- Georgetown University Hospital, Washington D.C.
- Medstar Washington Hosp Ctr, Washington D.C.
- Mid Atlantic Epilepsy and Sleep Ctr, Bethesda · 7 mi lwen
Central Nervous System Uptake of Anti-CD8+ T Cell Minibodies in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy
Ap rekriteFaz 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Pathological Basis of MRI Signal Changes in Multiple Sclerosis
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Genes and Environment in Multiple Sclerosis
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- National Institute of Neurological Disorders and Stroke, Bethesda · 7 mi lwen
A Study on the Safety of Ozanimod Exposure in Pregnant Women and Their Offspring
Ap rekriteEtid obsèvasyon
- Evidera INC., Bethesda · 7 mi lwen
- Evidera, Bethesda · 7 mi lwen
Etid Skleroz Miltip nan lòt vil
- New York City, NY17 etid
- Chicago, IL15 etid
- Boston, MA14 etid
- Cleveland, OH9 etid
- San Francisco, CA8 etid
- Birmingham, AL8 etid
- St. Louis, MO8 etid
- Kansas City, KS8 etid
- Aurora, CO7 etid
- Columbus, OH7 etid
- Baltimore, MD7 etid
- Houston, TX6 etid
Lòt etid nan Washington
- Kansè (tout kalite)58 etid
- Kansè Poumon ki pa ti selil55 etid
- Kansè nan tete46 etid
- Kansè Metastatik43 etid
- Kansè poumon41 etid
- Kansè pwostat38 etid
- Obèsite33 etid
- Kansè kolorektal29 etid
- Maladi kadyovaskilè28 etid
- Kansè vejik26 etid
- Leksemi mieloïd egi24 etid
- Kansè ovè23 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.